Quantum BioPharma Ltd. QNTM
Set alert
2.38 USD -0.06 -2.46%
At close · Oct 30
2.38 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
2.29 Day range 2.47
2.10 52-week range 12.54
- YTD
- -67.40%
- 1 year
- -81.02%
- Open
- 2.45
- Prev close
- 2.44
- Mkt cap
- 15.30M
- Vol
- 76.83K
- Avg vol
- 211.08K
- EPS
- -4.98
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.29
- High
- 2.47
- Forward P/E
- -0.41
- Beta
- 0.00
- Short ratio
- 0.09
- Inst. own
- 16.65%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 4.92
- 200-d avg
- 14.62
- 1y target
- 0.00
2Y chart
Events in this range
- Nov 11, 2024Earnings: -4.37; estimate -2.78; surprise -57.19%
Signals (80)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 30, 2026 | 1 day ago |
| RSI: Oversold | Oct 16, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 5, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 11, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 9, 2026 | 1 month ago |
| SMA: Bullish | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 26, 2026 | 2 months ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| SMA: Bearish | Aug 18, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 24, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 23, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 6, 2026 | 3 months ago |
| SMA: Bearish | Jun 3, 2026 | 5 months ago |
| MACD: Sell Signal | May 29, 2026 | 5 months ago |
| RSI: Overbought | May 20, 2026 | 5 months ago |
| RSI: Overbought | May 14, 2026 | 5 months ago |
| RSI: Overbought | Apr 29, 2026 | 6 months ago |
| SMA: Bullish | Apr 24, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 24, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 10, 2026 | 6 months ago |
| SMA: Bearish | Apr 8, 2026 | 6 months ago |
| SMA: Bullish | Apr 7, 2026 | 6 months ago |
| SMA: Bearish | Apr 6, 2026 | 6 months ago |
| SMA: Bullish | Mar 27, 2026 | 7 months ago |
| SMA: Bearish | Mar 26, 2026 | 7 months ago |
| SMA: Bullish | Mar 24, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 20, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 11, 2026 | 7 months ago |
| RSI: Oversold | Mar 10, 2026 | 7 months ago |
| RSI: Oversold | Feb 27, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 13, 2026 | 8 months ago |
| RSI: Oversold | Jan 28, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 22, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 16, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 29, 2025 | 10 months ago |
| SMA: Bearish | Dec 23, 2025 | 10 months ago |
| SMA: Bullish | Dec 22, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 25, 2025 | 11 months ago |
| RSI: Oversold | Oct 31, 2025 | 1 year ago |
| SMA: Bearish | Oct 28, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 9, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 12, 2025 | 1 year ago |
| RSI: Oversold | Sep 8, 2025 | 1 year ago |
| SMA: Bearish | Aug 18, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 13, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 4, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 31, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 18, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 27, 2025 | 1 year ago |
| RSI: Overbought | Jun 12, 2025 | 1 year ago |
| RSI: Overbought | Jun 6, 2025 | 1 year ago |
| RSI: Overbought | May 30, 2025 | 1 year ago |
| RSI: Overbought | May 21, 2025 | 1 year ago |
| RSI: Overbought | May 19, 2025 | 1 year ago |
| MACD: Buy Signal | May 2, 2025 | 1 year ago |
| SMA: Bullish | Apr 23, 2025 | 1 year ago |
| SMA: Bearish | Apr 14, 2025 | 1 year ago |
| SMA: Bullish | Apr 11, 2025 | 1 year ago |
| SMA: Bearish | Apr 10, 2025 | 1 year ago |
| SMA: Bullish | Apr 9, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 8, 2025 | 1 year ago |
| SMA: Bearish | Apr 7, 2025 | 1 year ago |
| SMA: Bullish | Mar 25, 2025 | 1 year ago |
| SMA: Bearish | Mar 21, 2025 | 1 year ago |
| SMA: Bullish | Mar 17, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 17, 2025 | 1 year ago |
| SMA: Bearish | Feb 27, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 19, 2025 | 1 year ago |
| SMA: Bullish | Feb 4, 2025 | 1 year ago |
| RSI: Overbought | Feb 4, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 3, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 27, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 21, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 15, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 30, 2024 | 1 year ago |
| RSI: Oversold | Dec 20, 2024 | 1 year ago |
Key statistics
- Market cap
- 6.16M
- Enterprise value
- -4.42M
- Trailing P/E
- 0.00
- Forward P/E
- -0.41
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.18
- EPS (TTM)
- -13.19
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -9.24M
- Total cash
- 6.61M
- Total debt
- 373.02K
- Return on equity
- -73.84%
- Shares outstanding
- 1.92M
- Short % of float
- 0.33%
- 50-day average
- 4.92
- 200-day average
- 14.62
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
QNTM Revenue — quarterly 0
QNTM Net income — quarterly -3.25M
QNTM EPS — quarterly -0.47
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 11, 2024 | Sep 1, 2024 | -2.78 | -4.37 | -1.59 | -57.19% |
About Quantum BioPharma Ltd.
Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd., is headquartered in Toronto, Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Canada
- Website
- quantumbiopharma.com
News
- Top Wall Street Forecasters Revamp Thermo Fisher Scientific Expectations Ahead Of Q3 Earnings
- World Renowned Law Firm Grant & Eisenhofer Appointed Lead Counsel In Newly Consolidated Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
- Thermo Fisher Scientific (NYSE:TMO) Sets New 52-Week High – Time to Buy?
- Quantum BioPharma Signs Contract with Thermo Fisher Scientific's Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis
- EXCLUSIVE: Thermo Fisher To Support Quantum Biopharma in Progressive Multiple Sclerosis Drug Trial
- IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd.
- Quantum BioPharma’s Licensee Unbuzzd Wellness Announces Appointment Of Michael Zapolin As CEO
- Quantum Biopharma Licensee Unbuzzd Wellness to Advance Clinically Validated Alcohol Metabolism Accelerant After Appointing Zappy as CEO
- Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target
- Quantum BioPharma to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto
Your note
Sign in to keep a note on QNTM — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| AdvisorShares Investments, LLC | 1.37% | 26,233 | 84.21K | Sep 29, 2024 |
| Virtu Financial LLC | 0.60% | 11,428 | 36.68K | Sep 29, 2024 |
| HRT Financial LP | 0.52% | 10,041 | 32.23K | Sep 29, 2024 |
| Royal Bank of Canada | 0.01% | 107 | 343 | Sep 29, 2024 |
| Group One Trading, L.P. | 0.01% | 172 | 552 | Sep 29, 2024 |
| National Bank of Canada/FI | 0.00% | 48 | 154 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| AdvisorShares Trust-AdvisorShares Psychedelics ETF | 3.69% | 70,898 | 227.58K | Oct 30, 2024 |